Clinical trial

Aralast NP in Islet Transplant

NCT02520076

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-08-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2015-08-01Date precision: month

Registry last updated2022-05-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetes Mellitusunresolved

Interventions

Alpha-1 AntitrypsinDRUG

Sponsors & collaborators

University of Albertalead sponsor

Shirecollaborator

Mapped research locations

EdmontonAlberta, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02520076 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.